Journal: Inflammatory Bowel Diseases
Article Title: Spironolactone and colitis: Increased mortality in rodents and in humans
doi: 10.1002/ibd.21929
Figure Lengend Snippet: (A) Spironolactone inhibits TGFβ induction of αSMA protein expression in colonic myofibroblasts. A representative Western blot of αSMA expression in protein extracts from CCD-18co colonic myofibroblasts stimulated for 24 h with TGFβ is shown. Increasing amounts of spironolactone (SPIR) from 10 μM to 100 μM reduce αSMA expression to levels comparable to unstimulated cells (no Tx). GAPDH expression serves as the loading control for the amount of protein. (B) Treatment of TGFβ stimulated CCD-18co cells with spironolactone (SPIR) represses expression of Acta2, Col1a1, and Ctgf. A metabolite of spironolactone, canrenone (CAN) partially represses pro-fibrotic gene expression. (C) The role of the RAAS pathway in fibrosis and the relationship of pathway inhibitors. (D) Inhibitors of the RAAS pathway aliskiren (ALK), enalaprilat (ENT), and losartan (LOR) partially repress TGFβ induction of fibrotic genes with partial repression of Acta2 expression but have minimal effect on Col1a1 expression (E). Results are from 9 independent experiments. Asterisks denote statistically significant comparisons between untreated control cells (no Tx) and the treatment groups. Brackets denote comparisons between TGFβ treated and other treatment groups. * P <0.05, *** P <0.001
Article Snippet: In vitro myofibroblast culture methods Early passage (3 to 12) colonic human fibroblast CCD-18Co cells (CRL-1459 from ATCC) were cultured in alpha-MEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum and sub-cultured weekly.
Techniques: Expressing, Western Blot, Control, Gene Expression